Rohatiner A(1994).“Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma.”.Ann Oncol.5(5): 397-400.PMID8075046.
Nakamura S(2012).“Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.”.Gut.61(4): 507-513.doi:10.1136/gutjnl-2011-300495..PMID21890816.
Thiede C(2001).“Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma.”.J Clin Oncol.19(6): 1600-1609.PMID11250988.
Raderer M(2003).“Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.”.Oncology65(4): 306-310.PMID14707449.
Raderer M(2006).“Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma.”.Oncology70(6): 411-417.PMID17220639.
Kahl B;Yang D(2008).“Marginal zone lymphomas: management of nodal, splenic, and MALT NHL.”.Hematology Am Soc Hematol Educ Program.: 359-364.doi:10.1182/asheducation-2008.1.359..PMID19074110.
Thieblemont C(2000).“Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed.”.Blood95(3): 802-806.PMID10648389.